
Editorial
Select search scope: search across all journals or within the current journal

Before death occurs from advanced prostate cancer, all patients pass through a ‘hormone resistant’ phase of the disease (HRPC). A large proportion of patients with advanced prostate cancer on hormonal therapy are managed in the Urology Outpatient Department, albeit with multidisciplinary input into their care. Chemotherapy for HRPC has now been shown to increase survival and quality of life and many novel agents are now undergoing Phase I and Phase II trials. The timely and appropriate referral of patients for chemotherapy, however, is essential in order to optimise patients' care and use chemotherapy wisely. This article addresses many of these practical issues.
In urology there is currently no validated and objective way to measure the ‘Relationship with Patients’ aspect of re-validation. The Sheffield Patient Assessment Tool (SHEFFPAT) questionnaire has been validated in a paediatric setting and is recommended by the Picker institute for patient feedback. The aim of this study is to assess the feasibility, reliability and validity of the SHEFFPAT questionnaire in urology to determine if it is an appropriate tool to be used for patient feedback.
Ten consultants in the North West Region gave permission for the SHEFFPAT questionnaire to be distributed to their patients. A minimum of 25 completed questionnaires was required per consultant. A detailed analysis looking at reliability, bias, feasibility and validity was then carried out.
In total there were 464 completed questionnaires. The cohort mean score was 4.66 (S.D. 0.19) ranging from 2.0 to 5.0. Twenty-three patients are needed to provide feedback in order to achieve a reliability of 0.7 (95% CI 0.21). The gender and ethnicity of the patient nor their familiarity with the urologist helped to explain the variability in scores (
The SHEFFPAT questionnaire appears to provide reliable, valid and unbiased feedback from the patients' perspective fulfilling the White Paper and Health Minister's request for patient involvement in the re-validation process.
Testicular ultrasound is a non-invasive and accurate investigation for testicular abnormalities. However, the majority of testicular problems are amenable to diagnosis by clinical examination alone. Testicular USS requests and reports generated over an 18-month period (03/2006 to 09/2007) at Nottingham City Hospital were examined to determine the indication for the test and the ultrasound findings. 2475 scans were performed: 576 were requested by urologists; 1899 by GPs and other hospital specialists. The most common findings were a completely normal scan (825) and epididymal cyst (637). In the majority of cases, the ultrasound scan was not necessary to make a diagnosis and added nothing to the findings at clinical examination. Correlations of ultrasound findings with the clinical reason for the test are presented in order to suggest suitable indications for this investigation. The total cost of testicular scans performed was around £200,000. It is estimated that at least £130,000 per year could be saved in a single hospital by avoiding unnecessary testicular scans. However, where the clinical findings are equivocal, ultrasound remains an excellent diagnostic tool.
Conventional, paper-based, urological referral has been challenged by the computer-based, choose and book (C&B) system. To determine the efficiency of this new system, we audited the appropriateness of these bookings, the percentage that required re-direction, the reasons for doing so and the ‘did not attend’ (DNA) rate.
1147 electronic bookings were made to different urological clinics between June 2006 and August 2007. The patient's age, date and type of clinic originally booked to, via C&B, and finally re-directed to was collected from our C&B record, PAS and Medisec. 1952 referrals via all modes were identified between April and November, 2006 and data on patient demographics, type of referral and whether attended or DNA was recorded.
Nearly a quarter of C&B appointments were re-directed, due to referrals being made to an inappropriate clinic, inappropriate consultant, inappropriate speciality, to the wrong hospital. Additionally, 32.3% were inappropriately prioritised, 7% being given inappropriate urgency and 25.3% not enough priority. DNA rate (18.9%) was higher for bookings made via C&B when compared to bookings made via standard paper-based GP referrals (15.3%).
Although C&B facilitates patients to make their choice of appointments, nearly a quarter of our patients had arrangements made inappropriate to their needs. This meant consultants still had to screen referrals and increased workload on ancillary staff. Despite being offered a choice, DNA rate was high in referrals via C&B. Refinement of C&B pathways may reduce this inefficiency but the inflexibility of this system makes it an inefficient way of referring urological cases.
Large volume centres from the USA suggest laparoscopic radical nephrectomy (LRN) for T2 (>7 cm) renal cell carcinoma (RCC) is safe and associated with few complications. Similar data for low and intermediate volume centres in Europe is lacking.
Data from 118 consecutive LRN performed in Oxford, UK (tertiary academic centre, catchment population 2,000,000) and Reading, UK (large district general hospital, catchment population 500,000). All patients undergoing LRN from 2004 to 2008 were included; outcome data were collected prospectively. All patients underwent a standard 4-port trans-peritoneal LRN with intact specimen removal. Patients were divided into two groups—Group 1 (clinical T1 tumours) and Group 2 (clinical T2 tumours). Demographic data and operative outcome data were collected for every patient including age, weight, operative duration, estimated blood loss, transfusion rates, complications, hospital stay and histology. Data were compared using Chi-square test and the Student
Mean patient age was 62.5 years; 57% of tumours were right sided. Mean tumour dimension in Group 1 was 4.3cm and 9.3cm in Group 2. Demographics were similar between the two groups. Operative duration, estimated blood loss and transfusion rates were significantly greater in Group 2. Despite this, complication rates, conversion rates and hospital stay were similar. 12% of tumours were benign and nearly half of all clinical T2 tumours were ultimately staged T3 on final histology.
LRN for T2 RCC can be performed safely in intermediate volume centres. The procedure is more challenging but operative outcomes are similar to LRN for smaller tumours. Many >7 cm RCC are T3 on final histology.




The European Working Time Directive (EWTD) poses challenges for out of hours management of the acute urological patient. With the introduction of the “Hospital at Night” team or cross specialty cover, there may be limited onsite urological experience out of hours. One of the commonest urological emergencies is acute stone colic. For the on call team to provide a safe and quality service, the BAUS Section of Endourology has produced guidelines for the emergency management of urolithiasis.
